These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31813835)

  • 1. Evaluation of an HIV recent infection testing algorithm with serological assays among men who have sex with men in Mexico.
    Karatzas-Delgado EF; Ruiz-González V; García-Cisneros S; Olamendi-Portugal ML; Herrera-Ortiz A; López-Gatell H; González-Rodríguez A; Sánchez-Alemán MA
    J Infect Public Health; 2020 Apr; 13(4):509-513. PubMed ID: 31813835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.
    Schlusser KE; Pilcher C; Kallas EG; Santos BR; Deeks SG; Facente S; Keating SM; Busch MP; Murphy G; Welte A; Quinn T; Eshleman SH; Laeyendecker O
    PLoS One; 2017; 12(2):e0172283. PubMed ID: 28231277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
    Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
    PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
    Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
    PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an antibody avidity index method for detecting recent human immunodeficiency virus type 1 infection using an automated chemiluminescence immunoassay.
    Fernández G; Manzardo C; Montoliu A; Campbell C; Fernández G; Casabona J; Miró JM; Matas L; Rivaya B; González V
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):238-42. PubMed ID: 25060663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workers.
    Braunstein SL; Nash D; Kim AA; Ford K; Mwambarangwe L; Ingabire CM; Vyankandondera J; van de Wijgert JH
    PLoS One; 2011 Apr; 6(4):e18402. PubMed ID: 21532753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological markers for identifying recent HIV infection in North-West India.
    Chauhan CK; Lakshmi PVM; Sagar V; Sharma A; Arora SK; Kumar R
    Indian J Med Res; 2020 Sep; 152(3):227-233. PubMed ID: 33107482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
    Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
    PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High avidity anti-integrase antibodies discriminate recent and non-recent HIV infection: Implications for HIV incidence assay.
    Rikhtegaran Tehrani Z; Azadmanesh K; Mostafavi E; Gharibzadeh S; Soori S; Azizi M; Khabiri A
    J Virol Methods; 2018 Mar; 253():5-10. PubMed ID: 29248529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a BioRad Avidity assay for identification of recent HIV-1 infections using dried serum or plasma spots.
    Hauser A; Heiden MA; Meixenberger K; Han O; Fiedler S; Hanke K; Koppe U; Hofmann A; Bremer V; Bartmeyer B; Kuecherer C; Bannert N
    J Virol Methods; 2019 Apr; 266():114-120. PubMed ID: 30738741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays.
    Hladik W; Olara D; Mermin J; Moore D; Were W; Alexander L; Downing R
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):95-9. PubMed ID: 21314476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.
    Lynch BA; Patel EU; Courtney CR; Nanfack AJ; Bimela J; Wang X; Eid I; Quinn TC; Laeyendecker O; Nyambi PN; Duerr R; Redd AD
    AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1114-1116. PubMed ID: 28670965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.
    Schlusser KE; Konikoff J; Kirkpatrick AR; Morrison C; Chipato T; Chen PL; Munjoma M; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):555-557. PubMed ID: 28318310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.